Cargando…
Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187021/ https://www.ncbi.nlm.nih.gov/pubmed/30344526 http://dx.doi.org/10.3389/fimmu.2018.02326 |
| _version_ | 1783362954429726720 |
|---|---|
| author | Kloess, Stephan Ede Valverde da Silva, Alessa Oberschmidt, Olaf Gardlowski, Tanja Matthies, Nadine Vyas, Maulik Arseniev, Lubomir Heuser, Michael Pogge von Strandmann, Elke Köhl, Ulrike |
| author_facet | Kloess, Stephan Ede Valverde da Silva, Alessa Oberschmidt, Olaf Gardlowski, Tanja Matthies, Nadine Vyas, Maulik Arseniev, Lubomir Heuser, Michael Pogge von Strandmann, Elke Köhl, Ulrike |
| author_sort | Kloess, Stephan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6187021 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61870212018-10-19 Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset Kloess, Stephan Ede Valverde da Silva, Alessa Oberschmidt, Olaf Gardlowski, Tanja Matthies, Nadine Vyas, Maulik Arseniev, Lubomir Heuser, Michael Pogge von Strandmann, Elke Köhl, Ulrike Front Immunol Immunology Frontiers Media S.A. 2018-10-08 /pmc/articles/PMC6187021/ /pubmed/30344526 http://dx.doi.org/10.3389/fimmu.2018.02326 Text en Copyright © 2018 Kloess, Ede Valverde da Silva, Oberschmidt, Gardlowski, Matthies, Vyas, Arseniev, Heuser, Pogge von Strandmann and Köhl. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Kloess, Stephan Ede Valverde da Silva, Alessa Oberschmidt, Olaf Gardlowski, Tanja Matthies, Nadine Vyas, Maulik Arseniev, Lubomir Heuser, Michael Pogge von Strandmann, Elke Köhl, Ulrike Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset |
| title | Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset |
| title_full | Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset |
| title_fullStr | Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset |
| title_full_unstemmed | Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset |
| title_short | Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset |
| title_sort | corrigendum: triplebody mediates increased anti-leukemic reactivity of il-2 activated donor natural killer (nk) cells and impairs viability of their cd33-expressing nk subset |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187021/ https://www.ncbi.nlm.nih.gov/pubmed/30344526 http://dx.doi.org/10.3389/fimmu.2018.02326 |
| work_keys_str_mv | AT kloessstephan corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset AT edevalverdedasilvaalessa corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset AT oberschmidtolaf corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset AT gardlowskitanja corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset AT matthiesnadine corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset AT vyasmaulik corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset AT arsenievlubomir corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset AT heusermichael corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset AT poggevonstrandmannelke corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset AT kohlulrike corrigendumtriplebodymediatesincreasedantileukemicreactivityofil2activateddonornaturalkillernkcellsandimpairsviabilityoftheircd33expressingnksubset |